March 5, 2020
Today, the U.S. Senate passed the Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074), a bipartisan spending package that provides $8.3 billion in new emergency funding to fight the coronavirus. The U.S. House passed the measure yesterday. President Trump said he will sign the bill.
- $950 million for state and local health agencies to conduct activities such as surveillance, laboratory testing, infection control, contact tracing, and mitigation;
- More than $3 billion for research and development of vaccines, therapeutics, and diagnostics;
- $2.2 billion for public health funding for prevention, preparedness, and response;
- Nearly $1 billion for procurement of pharmaceuticals and medical supplies, to support Community Health Centers, and to improve medical surge capacity;
- $434 million to support health systems overseas to prevent, prepare, and respond to the virus;
- $300 million to respond to humanitarian needs;
- $61 million to facilitate the development and review of medical countermeasures, devices, therapies, and vaccines, and to help mitigate potential supply chain interruptions; and
- Allowance for an estimated $7 billion in low-interest loans to affected small businesses.
U.S. Senate Democratic Whip Dick Durbin (D-IL), a member of the Senate Appropriations Committee, yesterday released a statement on the coronavirus emergency response supplemental funding bill. In it, Sen. Durbin noted that the Illinois Department of Public Health (IDPH) is expected to receive at least $14.7 million and the Chicago Department of Public Health (CDPH) is expected to receive an additional $8.7 million.
Separate from the emergency supplemental appropriations funding bill, the Centers for Disease Control and Prevention (CDC) announced yesterday a total of $2.75 million in initial funding for IDPH and $1.75 million in initial funding for CDPH for coronavirus surveillance, infection control, and surge staffing activities.